Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMYT

Amryt Pharma (AMYT) Stock Price, News & Analysis

Amryt Pharma logo

About Amryt Pharma Stock (NASDAQ:AMYT)

Advanced Chart

Key Stats

Today's Range
$14.63
$14.76
50-Day Range
$14.55
$14.70
52-Week Range
$6.41
$14.77
Volume
2.39 million shs
Average Volume
757,360 shs
Market Capitalization
$940.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter.

AMYT Stock News Headlines

Alembic Pharmaceuticals Ltd.
AMYT Historical Data
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
Amryt Pharma Stock (NASDAQ:AMYT), Dividends
See More Headlines

AMYT Stock Analysis - Frequently Asked Questions

Amryt Pharma plc (NASDAQ:AMYT) issued its quarterly earnings results on Thursday, November, 5th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.73) by $0.66. The business had revenue of $49.33 million for the quarter. Amryt Pharma had a negative net margin of 8.19% and a positive trailing twelve-month return on equity of 1.70%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amryt Pharma investors own include Alibaba Group (BABA), Dynavax Technologies (DVAX), Advanced Micro Devices (AMD), Teladoc Health (TDOC), NIO (NIO), Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2020
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AMYT
CIK
1783010
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1 million
Net Margins
-8.19%
Pretax Margin
-0.56%
Return on Equity
1.70%
Return on Assets
0.75%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.57
Quick Ratio
0.94

Sales & Book Value

Annual Sales
$222.54 million
Price / Sales
4.22
Cash Flow
$0.98 per share
Price / Cash Flow
14.98
Book Value
$5.58 per share
Price / Book
2.63

Miscellaneous

Outstanding Shares
63,960,000
Free Float
60,343,000
Market Cap
$940.21 million
Optionable
Not Optionable
Beta
0.84
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:AMYT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners